» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Cracking the code on opioid‑prescribing patterns in Nova Scotia
- Dalhousie Medicine New Brunswick launches first‑of‑its‑kind medical education podcast: The Fac Dev Lounge
- Reducing brain inflammation may be the key to slowing or even reversing cognitive decline associated with aging
- Award‑winning achievement: Researcher’s work shows how Canada's new cigarette packaging will curb smoking
- Simulation‑based education: bringing theory and practice together
- Shadowing a doctor: A student’s first day of medical school leaves a lasting impact
- Dr. Noni MacDonald to be invested into Order of Nova Scotia
- Dalhousie Medicine New Brunswick celebrates first PhD graduate from Research Department